iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
NCT ID: NCT04206748
Last Updated: 2021-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2019-11-12
2022-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women
NCT05453357
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
NCT05430204
Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor
NCT00011622
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
NCT06184373
Telemonitoring of Pregnancies Complicated With Gestational Diabetes Mellitus.
NCT06251466
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
iGlucose Smart Meter
iGlucose Smart Meter System
Subjects will have routine care enhanced by use of theThe iGlucose Smart meter system. This is an example of integration of a SMBG system with internet-based technology; including cell phone notifications for reminders, feedback, and communication with clinicians
Rx glucose meter
Routine Care-RX meter
Subjects will receive routine care with the insurance prescribed glucose meter. They will self manage with traditional diabetes diary.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iGlucose Smart Meter System
Subjects will have routine care enhanced by use of theThe iGlucose Smart meter system. This is an example of integration of a SMBG system with internet-based technology; including cell phone notifications for reminders, feedback, and communication with clinicians
Routine Care-RX meter
Subjects will receive routine care with the insurance prescribed glucose meter. They will self manage with traditional diabetes diary.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-anomalous singletons
* Ability to provide informed consent
Exclusion Criteria
* Patients with fetal major congenital abnormalities
* Patients identified/referred after 30.6 weeks
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Smart Meter Corporation
INDUSTRY
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joycelyn Ashby Cornthwaite
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-19-0402
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.